A study suggests that a planned follow-up of at least 15 years after PCa treatment is reasonable.
Human beings are unique in the animal kingdom when it comes to nutrition.
Patients with substance use disorder are more likely to be hospitalized and to make emergency department visits.
Experts note study findings aren't definitive, and risk is minimal.
Study finds a 19% increased risk of distant metastases or death from the cancer.
Those with depression, intermediate- or high-risk disease undergo less treatment.
Men who took cranberry capsules during and after external beam radiation treatment experienced less severe symptoms of cystitis.
Use of low-molecular-weight heparin decreased the risk of death by 52%.
In a study, the biochemical recurrence-free and metastasis-free survival rates were 73% and 97.5%, respectively, at 10 years.
Prostate cancer patients with health insurance are less likely to present with metastatic disease or die from the cancer than uninsured patients.
After 5 years, nearly two thirds of men remained on active surveillance.
Men aged 61 and older at diagnosis are more likely to die from the malignancy than men aged 50 or younger.
Transient rises in PSA after radiotherapy may be due to late damage to healthy prostatic tissue, evidence suggests.
Increased long-term risk observed in men on active surveillance.
Most physicians report that their patients are not interested in active surveillance.
Compared with whites, blacks and Hispanics have 42% and 23% increased odds, respectively, of being diagnosed with high-risk prostate cancer.
Other predictors include the presence of more than 1 positive biopsy core and a greater tumor burden.